BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
2817 results:

  • 1. Principles in the Management of Glioblastoma.
    Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
    Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
    Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management.
    Zhou M; Tang J; Fan J; Wen X; Shen J; Jia R; Chai P; Fan X
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100058. PubMed ID: 38615905
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (rb1/prb1) Pathway in Epithelial Ovarian Cancers.
    Lashen A; Algethami M; Alqahtani S; Shoqafi A; Sheha A; Jeyapalan JN; Mongan NP; Rakha EA; Madhusudan S
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612869
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/ERK signaling.
    Gao Y; Du P
    Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Strabismus management in retinoblastoma survivors.
    Masoomian B; Shields CL; Esfahani HR; Khalili A; Ghassemi F; Rishi P; Akbari MR; Khorrami-Nejad M
    BMC Ophthalmol; 2024 Mar; 24(1):114. PubMed ID: 38481156
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
    Ding J; Sun J; Ma RQ; Zheng K; Han YN
    Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
    Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. P53 and Rb Aberrations in Small cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation.
    Papavassiliou KA; Sofianidi AA; Gogou VA; Anagnostopoulos N; Papavassiliou AG
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473726
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review.
    Pi X; Zhang Q; Wang X; Jiang F
    Mol Genet Genomic Med; 2024 Mar; 12(3):e2414. PubMed ID: 38465842
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Generation and characterization of three CRISPR/Cas9 edited rb1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
    Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
    Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Characteristics of patients with recurrent retinoblastoma: a survival analysis.
    Li N; Wang YZ; Zhang Y; Zhang WL; Huang DS
    BMC Cancer; 2024 Mar; 24(1):287. PubMed ID: 38438837
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Management of Recurrence in Retinoblastoma Based on the Source of tumor cells.
    Thaker SK; Shah PK; Das A; Maitra P
    Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway.
    Chen J; Zeng B
    Crit Rev Immunol; 2024; 44(3):89-98. PubMed ID: 38421707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics.
    Hu X; Zhang D; Huang L; Zeng Z; Su Y; Chen S; Lin X; Hong S
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1830-1842. PubMed ID: 38408449
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 141.